The UK Endoscopy market was valued at USD 1,032 Million in 2025 and is projected to reach USD 2,370 Million by 2035, expanding at a CAGR of 7.9% from 2024 to 2035. The industry's growth is driven by technological advancements in minimally invasive procedures and surging demand for early diagnostic solutions.
The economic impact of tariffs on "UK Endoscopy".
UK Endoscopy Market Growth Drivers
Rising prevalence of gastrointestinal disorders: The incidence of GI conditions such as colorectal cancer and inflammatory bowel diseases has significantly increased in the UK. According to Olympus Corporation, there has been a 13% year-on-year escalation in diagnostic colonoscopies between 2022 and 2023, fueled by increased public awareness and NHS screening programs. This scenario is driving demand for advanced endoscopic systems and supporting equipment.
Technological advancements: Major players like Medtronic Plc. are introducing innovative endoscopic platforms with enhanced imaging, robotics, and AI capabilities. The introduction of Medtronic's GI Genius module in 2024, which uses artificial intelligence to support colorectal polyp detection, has received positive adoption among NHS trusts, highlighting how technological innovation is expanding the endoscopy market in the UK.
UK Endoscopy Market Trends
Shift towards single-use endoscopes: With infection-control concerns rising post-COVID-19, UK healthcare facilities are increasingly adopting single-use endoscopes. Ambu A/S, for instance, reported a 30% surge in UK sales for their disposable bronchoscope solutions in the last year, as hospitals prioritize patient safety and operational efficiency.
Integration of Artificial Intelligence (AI): NHS England, in collaboration with Pentax Medical, conducted trials of AI-assisted endoscopy solutions in early 2024, showing a 14% improvement in adenoma detection rates. This trend demonstrates a strong push towards incorporating AI and machine learning into endoscopic procedures, leading to improved patient outcomes and operational workflow.
UK Endoscopy Market Opportunities
Expansion of tele-endoscopy services: Companies like Stryker are investing in remote diagnostic support and real-time video consultation platforms, creating opportunities to extend endoscopic expertise to rural and underserved regions across the UK.
Growing market for therapeutic endoscopy: Boston Scientific is focusing R&D efforts on new therapeutic endoscopy devices for minimally invasive interventions, anticipating rapid adoption due to increased incidence rates of GI cancers and demand for in-procedure therapies.
The chart presents an impressive upward trajectory in the UK endoscopy market revenue, moving from USD 655 Million in 2020 to USD 2,370 Million by 2035. Noticeable acceleration occurs after 2025, catalyzed by advancements in AI-enabled endoscopy, NHS digitization initiatives, and the increasing burden of chronic gastrointestinal diseases. The market's consistent annual growth underlines the pivotal role of early disease detection and therapeutic capabilities, while reflecting robust industry investments and proactive policy measures. The projected CAGR of 7.9% highlights sustained market momentum and the UK’s robust adoption of next-generation endoscopic technologies.
UK Endoscopy Market Share by Region, 2025
In 2025, England dominates the UK endoscopy market with a 61% share, driven by the presence of numerous advanced NHS endoscopy centers and higher adoption of innovative procedures. Scotland and Wales follow with 16% and 11% shares respectively, each supported by targeted healthcare investments and improvement programs. Northern Ireland commands 7%, while 'Others' (Channel Islands, Isle of Man) represent 5%. The distribution underscores the centralization of endoscopy services in England while highlighting growth opportunities for market expansion in other UK regions.
Recent Developments in UK Endoscopy Market (Last 6 Months)
In April 2024, Pentax Medical launched its new INSPIRA video processor line in the UK, enabling superior 4K imaging and advanced image enhancement functionalities. Key NHS trusts—including Guy’s and St Thomas’—initiated early adoption trials, underscoring a rising focus on quality visualization for improved diagnostic outcomes.
Medtronic received UKCA marking for its latest PillCam Genius capsule endoscopy platform in March 2024. With expanded indications and AI-backed detection, this device is now being piloted in select NHS screening programs, promising to revolutionize non-invasive small bowel examinations.
Boston Scientific announced a strategic collaboration with the NHS in May 2024 to roll out its AXIOS Stent and Electrocautery Enhanced Delivery System across four major UK hospitals. The initiative targets enhanced minimally invasive endoscopic therapy for pancreato-biliary disorders, emphasizing complex-case capabilities and improved patient recovery rates.
Press Releases